-10.90 (-0.92%) Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe’.
The above information is a part of company’s filings submitted to BSE.